Company

Forma Therapeutics Holdings, Inc.

Headquarters: Watertown, MA, United States

Employees: 166

CEO: Mr. Frank D. Lee

NASDAQ: FMTX

Market Cap

$1.01 Billion

USD as of Oct. 1, 2022

Market Cap History

Forma Therapeutics Holdings, Inc. market capitalization over time

Evolution of Forma Therapeutics Holdings, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Forma Therapeutics Holdings, Inc.

Detailed Description

Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Forma Therapeutics Holdings, Inc. has the following listings and related stock indices.


Stock: NASDAQ: FMTX wb_incandescent

Details

Headquarters:

500 Arsenal Street

Suite 100

Watertown, MA 02472

United States

Phone: 617 679 1970